Find Paid Clinical Trials in North Carolina

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in North Carolina

Top of Directory » All Locations » United States » North Carolina




  • Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity

    Conditions:   Attention Deficit Hyperactivity Disorder;   Glucose Intolerance;   Obesity
    Intervention:   Drug: Lis-dexamphetamine
    Sponsors:   Duke University;   Shire Pharmaceutical Development
    Not yet recruiting - verified November 2009

  • Radiosurgery and Avastin for Recurrent Malignant Gliomas

    Condition:   Malignant Glioma
    Interventions:   Radiation: Radiosurgery;   Drug: Bevacizumab
    Sponsors:   Duke University;   Genentech
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Optimal Planning Target Volume With Stereotactic Radiosurgery

    Conditions:   Brain Neoplasms;   Brain Cancer
    Intervention:   Radiation: Stereotactic Radiosurgery
    Sponsor:   Duke University
    Not yet recruiting - verified November 2009

  • Panitumumab and Irinotecan for Malignant Gliomas

    Condition:   Recurrent Grade IV Malignant Glioma
    Intervention:   Drug: Panitumumab in Combination with Irinotecan
    Sponsors:   Duke University;   Amgen
    Not yet recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

    Condition:   Liver Cancer
    Interventions:   Drug: doxorubicin hydrochloride;   Drug: mitomycin C;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   UNC Lineberger Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified July 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Study of Immunotoxin, MR1-1

    Condition:   Supratentorial Malignant Brain Tumor
    Intervention:   Biological: MR1-1
    Sponsors:   Duke University;   National Institutes of Health (NIH)
    Recruiting - verified November 2009

  • Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

    Conditions:   Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
    Interventions:   Biological: panitumumab;   Drug: paclitaxel;   Drug: carboplatin;   Procedure: laboratory biomarker analysis;   Procedure: immunohistochemistry staining method
    Sponsor:   Wake Forest University
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism

    Conditions:   Rhinitis;   Urticaria
    Intervention:   Drug: levocetirizine or placebo
    Sponsors:   Wake Forest University;   UCB, Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Wound Healing of Incisional Wounds for Bilateral Hernia Repair

    Condition:   Wound Healing
    Interventions:   Drug: Dermabond;   Drug: Hydrogen Peroxide Oxygen producing gel
    Sponsor:   Wake Forest University
    Recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Study Evaluating Two Dose Levels of Targetin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)

    Condition:   Refractory Cutaneous T-cell Lymphoma
    Interventions:   Drug: bexarotene;   Drug: bexarotene
    Sponsor:   Eisai Inc.
    Not yet recruiting - verified November 2009

  • A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

    Condition:   COPD
    Intervention:   Drug: R7103
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • TRAUMA HELP: Healing and Analgesia With Propranolol

    Condition:   Trauma
    Interventions:   Drug: Propranolol;   Drug: Propranolol ER;   Drug: Sugar pills
    Sponsor:   The University of North Carolina, Chapel Hill
    Recruiting - verified November 2009

  • Tetracaine Combined Spinal Epidural (CSE) vs Bupivacaine CSE

    Conditions:   Labor Pain;   Analgesia
    Interventions:   Drug: Tetracaine;   Drug: Bupivacaine
    Sponsor:   Wake Forest University
    Recruiting - verified October 2009

  • Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: Southern blotting;   Genetic: cytogenetic analysis;   Genetic: polymerase chain reaction
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Leukemia
    Interventions:   Genetic: fluorescence in situ hybridization;   Genetic: mutation analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: flow cytometry;   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

    Condition:   Leukemia
    Intervention:   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

    Conditions:   Excessive Daytime Sleepiness;   Narcolepsy
    Interventions:   Drug: Placebo;   Drug: PF-03654746
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Golimumab in Rheumatoid Arthritis Patients With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

    Conditions:   Arthritis;   Arthritis, Rheumatoid;   Autoimmune Diseases
    Interventions:   Drug: golimumab;   Drug: golimumab or placebo;   Drug: golimumab or placebo
    Sponsors:   Centocor, Inc.;   Schering-Plough
    Recruiting - verified November 2009

  • Intensive Lipid-Lowering Therapy for Patients With Acute Coronary Syndrome

    Condition:   Acute Coronary Syndrome
    Interventions:   Procedure: Percutaneous coronary intervention;   Procedure: Intravascular ultrasound with virtual histology;   Drug: Atorvastatin;   Device: LDL-apheresis
    Sponsor:   Department of Veterans Affairs
    Not yet recruiting - verified October 2009

  • Physiological Effects of Yogurt With Bb12 in Subjects With GI Symptoms Strointestinal Symptoms

    Condition:   Non-diarrhea Functional Bowel Symptoms
    Interventions:   Other: A probiotic yogurt with inulin;   Other: Acidified dairy snack
    Sponsors:   The University of North Carolina, Chapel Hill;   General Mills Inc.
    Recruiting - verified October 2009

  • Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma

    Conditions:   Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
    Intervention:   Drug: Avastin in Combination with Radiation and Temozolomide followed by Avastin, Temozolomide, and Topotecan
    Sponsors:   Duke University;   Genentech;   GlaxoSmithKline
    Not yet recruiting - verified October 2009

  • Bariatric Outcomes Longitudinal Database (BOLD)

    Conditions:   Obesity;   Overweight;   Diabetes
    Intervention:  
    Sponsor:   Surgical Review Corporation
    Recruiting - verified November 2009

  • Nipple Sparing Mastectomy

    Conditions:   Breast Cancer;   Breast Reconstruction
    Intervention:   Procedure: Nipple Sparing Mastectomy
    Sponsor:   Carolinas Healthcare System
    Recruiting - verified October 2009

  • Internet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans

    Condition:   Smoking Cessation
    Interventions:   Behavioral: Internet-based;   Behavioral: Standard Clinic-Based
    Sponsor:   Department of Veterans Affairs
    Not yet recruiting - verified October 2009

  • Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

    Conditions:   Graft-Versus-Host Disease;   Immune System Disorders
    Interventions:   Drug: Mycophenolate Mofetil;   Drug: Placebo
    Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Newtwork (BMT CTN)
    Not yet recruiting - verified October 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury

    Condition:   Drug Induced Liver Injury
    Intervention:  
    Sponsor:   The University of North Carolina, Chapel Hill
    Recruiting - verified October 2009

  • Study of Tissue and Blood Samples in Women With Locally Advanced or Metastatic Breast Cancer Undergoing Chemotherapy Before Surgery

    Condition:   Breast Cancer
    Interventions:   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Procedure: biopsy
    Sponsors:   UNC Lineberger Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified October 2009

  • Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure

    Condition:   Heart Failure
    Interventions:   Other: Daxor Blood Volume Analysis;   Other: Clinical volume status assessment
    Sponsors:   New York University School of Medicine;   Daxor Corporation
    Not yet recruiting - verified October 2009

  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen

    Conditions:   Overactive Bladder;   Constipation;   Lower Urinary Tract Symptoms
    Interventions:   Drug: Baclofen;   Drug: Placebo Comparator: Placebo
    Sponsor:   Wake Forest University
    Recruiting - verified October 2009

  • Establishment of Cell Culture Systems From Discarded Operating Room Tissue

    Condition:   Surgery
    Intervention:  
    Sponsors:   Wake Forest University;   Department of Defense
    Recruiting - verified October 2009

  • Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases

    Conditions:   Lysosomal Storage Diseases;   Inborn Errors of Metabolism
    Intervention:   Biological: ALD-601
    Sponsors:   Duke University;   Aldagen
    Recruiting - verified October 2009

  • Shanghai Parkinson's Study

    Condition:   Parkinson's Disease
    Intervention:  
    Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
    Recruiting - verified September 2009

  • Moderate to Persistent Asthma in the Obese Subject

    Condition:   Asthma
    Interventions:   Drug: Montelukast;   Other: Sugar pill
    Sponsor:   Duke University
    Not yet recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

    Condition:   Type II Diabetes Mellitus
    Interventions:   Drug: JTT-654;   Drug: JTT-654 Placebo
    Sponsor:   Akros Pharma Inc.
    Recruiting - verified November 2009

  • The Women's HIV SeroIncidence Study (ISIS)

    Condition:   HIV Infections
    Intervention:  
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified June 2009

  • Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

    Condition:   Aspirin-Associated Gastric Ulcers
    Intervention:   Drug: PA32540
    Sponsor:   Pozen
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials